Apollo Strategic Growth Capital II, a blank check company formed by Apollo targeting growth-oriented businesses, raised $600 million by offering 60 million units at $10. Each unit consists of one share of common stock and one-fifth of a warrant, exercisable...read more
Apollo Strategic Growth Capital II, the second blank check company formed by Apollo targeting growth-oriented businesses, raised the proposed deal size for its upcoming IPO on Thursday. The New York, NY-based company now plans to raise $500 million by...read more
In a staggering start to 2021, two biotechs and 28 SPACs raised over $7.1 billion in the first week of the new year. Activity should remain high as new filings continued to flood the IPO pipeline. Chinese cancer biotech ...read more
Apollo Strategic Growth Capital II, the second blank check company formed by Apollo targeting growth-oriented businesses, filed on Wednesday with the SEC to raise up to $400 million in an initial public offering. The New York-based company plans to...read more
Apollo Global's SPAC, Apollo Strategic Growth Capital II prices upsized $600 million IPO
Apollo Strategic Growth Capital II, a blank check company formed by Apollo targeting growth-oriented businesses, raised $600 million by offering 60 million units at $10. Each unit consists of one share of common stock and one-fifth of a warrant, exercisable...read more
Apollo Global's SPAC Apollo Strategic Growth Capital II raises deal size by 25% ahead of $500 million IPO
Apollo Strategic Growth Capital II, the second blank check company formed by Apollo targeting growth-oriented businesses, raised the proposed deal size for its upcoming IPO on Thursday. The New York, NY-based company now plans to raise $500 million by...read more
US IPO Weekly Recap: The new year kicks off with 2 biotech IPOs and a tidal wave of SPACs
In a staggering start to 2021, two biotechs and 28 SPACs raised over $7.1 billion in the first week of the new year. Activity should remain high as new filings continued to flood the IPO pipeline. Chinese cancer biotech ...read more
Apollo Global Management's SPAC Apollo Strategic Growth Capital II files for a $400 million IPO
Apollo Strategic Growth Capital II, the second blank check company formed by Apollo targeting growth-oriented businesses, filed on Wednesday with the SEC to raise up to $400 million in an initial public offering. The New York-based company plans to...read more